Modulation of cell cycle regulators by HDACs

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 3, 2012, Pages 831-839

  Telles, Elphine ^a   Seto, Edward ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cell cycle; E2F; HDAC; P53; Rb; Review; Sin3

Indexed keywords

ACETIC ACID DERIVATIVE; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; LYSINE; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR SIN3; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN;

ARTICLE; CANCER CELL; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CHROMATIN; CHROMATIN STRUCTURE; DEACETYLATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE REPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE DEACETYLATION; MODULATION; NONHUMAN; PROMOTER REGION; PROTEIN CONFORMATION; CELL CYCLE; CELL GROWTH; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

CELL CYCLE; CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; HISTONE DEACETYLASES; HISTONES; HUMANS; LYSINE; NEOPLASMS;

EID: 84869475619     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Isenberg, I.: Histones. Annu Rev Biochem, 48, 159-91 (1979)
2. Strahl, B. D. & C. D. Allis: The language of covalent histone modifications. Nature, 403, 41-5 (2000) (Pubitemid 30038513)
3. Wolffe, A. P. & J. J. Hayes: Chromatin disruption and modification. Nucleic Acids Res, 27, 711-20 (1999) (Pubitemid 29209356)
4. Sterner, D. E. & S. L. Berger: Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev, 64, 435-59 (2000) (Pubitemid 30412680)
5. Choudhary, C., C. Kumar, F. Gnad, M. L. Nielsen, M. Rehman, T. C. Walther, J. V. Olsen & M. Mann: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science, 325, 834-40 (2009)
6. Marks, P. A.: The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin Investig Drugs, 19, 1049-66 (2010)
7. Marks, P. A., V. M. Richon & R. A. Rifkind: Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst, 92, 1210-6 (2000) (Pubitemid 30627729)
8. Marks, P. A., R. A. Rifkind, V. M. Richon & R. Breslow: Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res, 7, 759-60 (2001) (Pubitemid 32708707)
9. Taunton, J., C. A. Hassig & S. L. Schreiber: A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science, 272, 408-11 (1996) (Pubitemid 26138177)
10. Yang, X. J. & E. Seto: Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr Opin Genet Dev, 13, 143-53 (2003) (Pubitemid 36369738)
11. Gregoretti, I. V., Y. M. Lee & H. V. Goodson: Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol, 338, 17-31 (2004) (Pubitemid 38429783)
12. Yang, X. J. & E. Seto: The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol, 9, 206-18 (2008) (Pubitemid 351301825)
13. Peserico, A. & C. Simone: Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol, 2011, 371832 (2011)
14. Vidal, M. & R. F. Gaber: RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae. Mol Cell Biol, 11, 6317-27 (1991) (Pubitemid 21895404)
15. McKinsey, T. A., C. L. Zhang, J. Lu & E. N. Olson: Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature, 408, 106-11 (2000)
16. Yang, X. J. & S. Gregoire: Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol, 25, 2873-84 (2005) (Pubitemid 40464294)
17. Cress, W. D. & E. Seto: Histone deacetylases, transcriptional control, and cancer. J Cell Physiol, 184, 1-16 (2000) (Pubitemid 30349623)
18. Ahringer, J.: NuRD and SIN3 histone deacetylase complexes in development. Trends Genet, 16, 351-6 (2000) (Pubitemid 30628836)
19. Denu, J. M.: The Sir 2 family of protein deacetylases. Curr Opin Chem Biol, 9, 431-40 (2005)
20. Michan, S. & D. Sinclair: Sirtuins in mammals: insights into their biological function. Biochem J, 404, 1-13 (2007) (Pubitemid 46788079)
21. Donmez, G. & L. Guarente: Aging and disease: connections to sirtuins. Aging Cell, 9, 285-90 (2011)
22. Canto, C. & J. Auwerx: Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab, 20, 325-31 (2009)
23. Finkel, T., C. X. Deng & R. Mostoslavsky: Recent progress in the biology and physiology of sirtuins. Nature, 460, 587-91 (2009)
24. Michishita, E., J. Y. Park, J. M. Burneskis, J. C. Barrett & I. Horikawa: Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell, 16, 4623-35 (2005) (Pubitemid 41416446)
25. Schwer, B., B. J. North, R. A. Frye, M. Ott & E. Verdin: The human silent information regulator (Sir) 2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol, 158, 647-57 (2002) (Pubitemid 34920104)
26. Yamamoto, H., K. Schoonjans & J. Auwerx: Sirtuin functions in health and disease. Mol Endocrinol, 21, 1745-55 (2007) (Pubitemid 47173788)
27. Glozak, M. A., N. Sengupta, X. Zhang & E. Seto: Acetylation and deacetylation of non-histone proteins. Gene, 363, 15-23 (2005) (Pubitemid 41691888)
28. Nurse, P.: Ordering S phase and M phase in the cell cycle. Cell, 79, 547-50 (1994) (Pubitemid 24363797)
29. Sherr, C. J. & J. M. Roberts: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev, 13, 1501-12 (1999) (Pubitemid 29297917)
30. Pearce, A. K. & T. C. Humphrey: Integrating stressresponse and cell-cycle checkpoint pathways. Trends Cell Biol, 11, 426-33 (2001) (Pubitemid 32900605)
31. Abraham, R. T.: Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev, 15, 2177-96 (2001) (Pubitemid 32843830)
32. Bartek, J. & J. Lukas: Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell, 3, 421-9 (2003) (Pubitemid 38340288)
33. Weinberg, R. A.: The retinoblastoma protein and cell cycle control. Cell, 81, 323-30 (1995)
34. Muller, H. & K. Helin: The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta, 1470, M1-12 (2000) (Pubitemid 30070163)
35. Stevaux, O. & N. J. Dyson: A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol, 14, 684-91 (2002) (Pubitemid 35449380)
36. Trimarchi, J. M. & J. A. Lees: Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol, 3, 11-20 (2002) (Pubitemid 135709914)
37. Leone, G., J. DeGregori, Z. Yan, L. Jakoi, S. Ishida, R. S. Williams & J. R. Nevins: E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev, 12, 2120-30 (1998) (Pubitemid 28348036)
38. DeGregori, J., T. Kowalik & J. R. Nevins: Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes. Mol Cell Biol, 15, 4215-24 (1995)
39. Bagchi, S., R. Weinmann & P. Raychaudhuri: The retinoblastoma protein copurifies with E2F-I, an E1Aregulated inhibitor of the transcription factor E2F. Cell, 65, 1063-72 (1991) (Pubitemid 121001694)
40. Lukas, J., J. Bartkova, M. Rohde, M. Strauss & J. Bartek: Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol, 15, 2600-11 (1995)
41. Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister & T. Kouzarides: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature, 391, 597-601 (1998) (Pubitemid 28157603)
42. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche & A. Harel-Bellan: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature, 391, 601-5 (1998) (Pubitemid 28157604)
43. Lai, A., B. K. Kennedy, D. A. Barbie, N. R. Bertos, X. J. Yang, M. C. Theberge, S. C. Tsai, E. Seto, Y. Zhang, A. Kuzmichev, W. S. Lane, D. Reinberg, E. Harlow & P. E. Branton: RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol, 21, 2918-32 (2001) (Pubitemid 32244934)
44. Martinez-Balbas, M. A., U. M. Bauer, S. J. Nielsen, A. Brehm & T. Kouzarides: Regulation of E2F1 activity by acetylation. The EMBO journal, 19, 662-71 (2000) (Pubitemid 30093739)
45. Marzio, G., C. Wagener, M. I. Gutierrez, P. Cartwright, K. Helin & M. Giacca: E2F family members are differentially regulated by reversible acetylation. The Journal of biological chemistry, 275, 10887-92 (2000) (Pubitemid 30212722)
46. Wang, H., I. Clark, P. R. Nicholson, I. Herskowitz & D. J. Stillman: The Saccharomyces cerevisiae SIN3 gene, a negative regulator of HO, contains four paired amphipathic helix motifs. Mol Cell Biol, 10, 5927-36 (1990)
47. Ayer, D. E., Q. A. Lawrence & R. N. Eisenman: Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell, 80, 767-76 (1995)
48. Dannenberg, J. H., G. David, S. Zhong, J. van der Torre, W. H. Wong & R. A. Depinho: mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes & development, 19, 1581-95 (2005) (Pubitemid 41003001)
49. Hassig, C. A., T. C. Fleischer, A. N. Billin, S. L. Schreiber & D. E. Ayer: Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell, 89, 341-7 (1997) (Pubitemid 27220878)
50. David, G., K. B. Grandinetti, P. M. Finnerty, N. Simpson, G. C. Chu & R. A. Depinho: Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proceedings of the National Academy of Sciences of the United States of America, 105, 4168-72 (2008) (Pubitemid 351754352)
51. Zupkovitz, G., R. Grausenburger, R. Brunmeir, S. Senese, J. Tischler, J. Jurkin, M. Rembold, D. Meunier, G. Egger, S. Lagger, S. Chiocca, F. Propst, G. Weitzer & C. Seiser: The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. Molecular and cellular biology, 30, 1171-81 (2010)
52. Lagger, G., D. O'Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer, B. Schuettengruber, C. Hauser, R. Brunmeir, T. Jenuwein & C. Seiser: Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. The EMBO journal, 21, 2672-81 (2002) (Pubitemid 34619383)
53. Wilting, R. H., E. Yanover, M. R. Heideman, H. Jacobs, J. Horner, J. van der Torre, R. A. DePinho & J. H. Dannenberg: Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. The EMBO journal, 29, 2586-97 (2010)
54. Bhaskara, S., B. J. Chyla, J. M. Amann, S. K. Knutson, D. Cortez, Z. W. Sun & S. W. Hiebert: Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Molecular cell, 30, 61-72 (2008) (Pubitemid 351470157)
55. Warbrick, E.: The puzzle of PCNA's many partners. BioEssays: news and reviews in molecular, cellular and developmental biology, 22, 997-1006 (2000)
56. Milutinovic, S., Q. Zhuang & M. Szyf: Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification. The Journal of biological chemistry, 277, 20974-8 (2002) (Pubitemid 34967408)
57. Mariadason, J. M., D. H. Barkla & P. R. Gibson: Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. The American journal of physiology, 272, G705-12 (1997)
58. Mariadason, J. M., K. L. Rickard, D. H. Barkla, L. H. Augenlicht & P. R. Gibson: Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. Journal of cellular physiology, 183, 347-54 (2000) (Pubitemid 30243865)
59. Mariadason, J. M., A. Velcich, A. J. Wilson, L. H. Augenlicht & P. R. Gibson: Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology, 120, 889-99 (2001) (Pubitemid 32193186)
60. Heerdt, B. G., M. A. Houston & L. H. Augenlicht: Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer research, 54, 3288-93 (1994)
61. Gurvich, N., O. M. Tsygankova, J. L. Meinkoth & P. S. Klein: Histone deacetylase is a target of valproic acidmediated cellular differentiation. Cancer research, 64, 1079-86 (2004) (Pubitemid 38176913)
62. Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts & C. J. Sherr: The p21 (Cip1) and p27 (Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. The EMBO journal, 18, 1571-83 (1999) (Pubitemid 29127070)
63. Doetzlhofer, A., H. Rotheneder, G. Lagger, M. Koranda, V. Kurtev, G. Brosch, E. Wintersberger & C. Seiser: Histone deacetylase 1 can repress transcription by binding to Sp1. Molecular and cellular biology, 19, 5504-11 (1999) (Pubitemid 29339908)
64. Lagger, G., A. Doetzlhofer, B. Schuettengruber, E. Haidweger, E. Simboeck, J. Tischler, S. Chiocca, G. Suske, H. Rotheneder, E. Wintersberger & C. Seiser: The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Molecular and cellular biology, 23, 2669-79 (2003) (Pubitemid 36403069)
65. Davie, J. R.: Inhibition of histone deacetylase activity by butyrate. The Journal of nutrition, 133, 2485S-2493S (2003) (Pubitemid 36828858)
66. Wilson, A. J., D. S. Byun, N. Popova, L. B. Murray, K. L'Italien, Y. Sowa, D. Arango, A. Velcich, L. H. Augenlicht & J. M. Mariadason: Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. The Journal of biological chemistry, 281, 13548-58 (2006) (Pubitemid 43855268)
67. Fischle, W., F. Dequiedt, M. J. Hendzel, M. G. Guenther, M. A. Lazar, W. Voelter & E. Verdin: Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Molecular cell, 9, 45-57 (2002) (Pubitemid 34127770)
68. Guenther, M. G., W. S. Lane, W. Fischle, E. Verdin, M. A. Lazar & R. Shiekhattar: A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes & development, 14, 1048-57 (2000) (Pubitemid 30324419)
69. Li, J., J. Wang, Z. Nawaz, J. M. Liu, J. Qin & J. Wong: Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. The EMBO journal, 19, 4342-50 (2000) (Pubitemid 30623745)
70. Codina, A., J. D. Love, Y. Li, M. A. Lazar, D. Neuhaus & J. W. Schwabe: Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. Proceedings of the National Academy of Sciences of the United States of America, 102, 6009-14 (2005) (Pubitemid 40594246)
71. Panteleeva, I., C. Rouaux, Y. Larmet, S. Boutillier, J. P. Loeffler & A. L. Boutillier: HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons. Annals of the New York Academy of Sciences, 1030, 656-60 (2004) (Pubitemid 40378965)
72. Wilson, A. J., D. S. Byun, S. Nasser, L. B. Murray, K. Ayyanar, D. Arango, M. Figueroa, A. Melnick, G. D. Kao, L. H. Augenlicht & J. M. Mariadason: HDAC4 promotes growth of colon cancer cells via repression of p21. Molecular biology of the cell, 19, 4062-75 (2008)
73. Zhang, Y., M. Tuzova, Z. X. Xiao, W. W. Cruikshank & D. M. Center: Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. Journal of immunology, 180, 402-8 (2008)
74. Center, D. M., W. W. Cruikshank & Y. Zhang: Nuclear pro-IL-16 regulation of T cell proliferation: p27 (KIP1) - dependent G0/G1 arrest mediated by inhibition of Skp2 transcription. Journal of immunology, 172, 1654-60 (2004) (Pubitemid 38116813)
75. Carrano, A. C., E. Eytan, A. Hershko & M. Pagano: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature cell biology, 1, 193-9 (1999) (Pubitemid 129500937)
76. Tsvetkov, L. M., K. H. Yeh, S. J. Lee, H. Sun & H. Zhang: p27 (Kip1) ubiquitination and degradation is regulated by the SCF (Skp2) complex through phosphorylated Thr187 in p27. Current biology: CB, 9, 661-4 (1999)
77. Margariti, A., A. Zampetaki, Q. Xiao, B. Zhou, E. Karamariti, D. Martin, X. Yin, M. Mayr, H. Li, Z. Zhang, E. De Falco, Y. Hu, G. Cockerill, Q. Xu & L. Zeng: Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circulation research, 106, 1202-11 (2010)
78. Gu, W. & R. G. Roeder: Activation of p53 sequencespecific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606 (1997) (Pubitemid 27357952)
79. Freedman, D. A., L. Wu & A. J. Levine: Functions of the MDM2 oncoprotein. Cellular and molecular life sciences: CMLS, 55, 96-107 (1999) (Pubitemid 29077858)
80. Ito, A., Y. Kawaguchi, C. H. Lai, J. J. Kovacs, Y. Higashimoto, E. Appella & T. P. Yao: MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. The EMBO journal, 21, 6236-45 (2002) (Pubitemid 35415340)
81. Vaziri, H., S. K. Dessain, E. Ng Eaton, S. I. Imai, R. A. Frye, T. K. Pandita, L. Guarente & R. A. Weinberg: hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell, 107, 149-59 (2001) (Pubitemid 33035942)
82. Luo, J., A. Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente & W. Gu: Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell, 107, 137-48 (2001) (Pubitemid 33035941)
83. Li, S., M. Banck, S. Mujtaba, M. M. Zhou, M. M. Sugrue & M. J. Walsh: p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS One, 5, e10486 (2010)